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PURPOSE: To evaluate the outcomes and diagnostic performance of ultrasonography after a Breast Imaging
Reporting and Data System (Bi-RADS) category 0 mammogram.
MATERIAL AND METHODS: This retrospective study reviewed 4,384 consecutive patients who underwent a
screening mammography from January 2005 to July 2006; 391 of the 4,384 exams were classified as Bi-RADS
category 0. After exclusions, 241 patients received subsequent sonogram. Ultrasonography was considered
diagnostic when the Bi-RADS category was changed to 2, 4, or 5, and it was considered indeterminate (Bi-RADS 3)
when the results indicated that the patients should return for a mammographic follow-up. The outcomes of these
patients were assessed to evaluate the diagnostic performance of ultrasonography.
RESULTS: The mean age of the patients was 53.3 years (ranging from 35 to 81). Of the 241 patients, ultrasonography
was considered diagnostic in 146 (60.6%) patients and indeterminate in 95 (39.4%) patients. In the diagnostic
group, 111 out of 146 patients (70.2%) had a sonogram result of Bi-RADS category 2 after a 2-year follow-up
without evidence of malignancy. Furthermore, 35 out of 146 patients (29.8%) had a suspicious sonogram with a
result of Bi-RADS category 4. After a tissue sampling procedure, 10 patients were confirmed to have breast cancer,
and 25 had benign histopathological features without any evidence of malignancy after a 2-year follow-up. The
sensitivity of ultrasonography was 100%, specificity was 89.1%, and overall accuracy was 89.6%.
CONCLUSIONS: Based on the degree of resolution and its diagnostic performance, ultrasonography was determined
to be an excellent method for the subsequent evaluation of Bi-RADS 0 mammograms.
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INTRODUCTION
The imaging approach for the evaluation of breast lesions
was standardized with the introduction of the Breast
Imaging Reporting Data System (Bi-RADS), which was
created by the American College of Radiology (ACR) in
1992.1 This systematization is a data control system that
provides a lexicon for describing lesions, establishes levels
of suspicion for breast cancer, and indicates the required
subsequent steps for the evaluation and treatment of breast
cancer. Six categories exist for breast lesions in Bi-RADS. An
extra category, Bi-RADS 0, is reserved for situations in
which an additional method may improve lesion character-
ization. Ultrasonography (US) plays an important role in the
detection of breast lesions that are either palpable or only
detected by imaging. Over the last 30 years, a consensus has
been reached regarding the indications for breast sonogra-
phy.2-4 US is the current choice for the evaluation of dense
breasts in young patients, the differentiation of cystic and
solid lesions, and for guidance procedures. The capability of
US as a screening method for breast cancer remains
controversial.5-10 Nonetheless, US has traditionally been
the preferred adjunctive method when further evaluation is
required after mammography.11-12 However, the impact of
sonography after a Bi-RADS 0 mammogram has not been
thoroughly investigated in the literature. Although some
authors have addressed the value of US in Bi-RADS
categories 3 to 5,13-14 no studies have assessed US
Copyright  2011 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
CLINICS 2011;66(3):443-448 DOI:10.1590/S1807-59322011000300014
443
performance and its resolution after a Bi-RADS category 0
mammography.
Therefore, we conducted this retrospective study to
investigate the performance of US as a secondary diagnostic
tool and to assess the outcome of mammograms that were
initially classified as Bi-RADS category 0.
MATERIALS AND METHODS
Study Design
This retrospective study was approved by the Institu-
tional Review Board of our institution. Informed consent
was not required. All consecutive screening mammography
data collected between January 2005 and July 2006 were
reviewed in the institutional database. Our institution
performs both screening and diagnostic mammographies.
Mammograms that were classified as Bi-RADS category 0
were extracted for further evaluation. For each patient, we
recorded the method used, the results obtained, and the
approach adopted after the additional imaging. Medical
records were reviewed to determine the final outcome of the
patients. The inclusion criteria for this study were as
follows: a) patients with Bi-RADS category 0 mammograms
that were further evaluated by US and b) patients without
tissue sampling who had histopathological diagnoses and/
or a two-year follow-up. A two-year follow-up interval was
chosen because it is the period of time normally used in the
literature to define stable lesions.1,9 Exclusion criteria were
as follows: a) patients with palpable lesions, b) patients
whose mammograms were classified as Bi-RADS category 0
(i.e., further evaluation) because a previous examination
was not available, c) patients who had a previous diagnosis
of breast cancer, and d) patients who were participating in
follow-up studies for lesions that were proven benign,
whether with or without breast manipulation.
Imaging techniques
All mammograms were performed using a DMR
Mammography System from GE Medical Systems,
Milwaukee, USA. Our protocol consisted of routine cranio-
caudal and oblique mediolateral views for both breasts.
Additional tests, such as magnification, compression, axilar,
and other views, were performed if necessary. All ultra-
sound exams were performed with real-time, dynamic
equipment (Acuson Aspen, Acuson-Siemens, Mountain
View, California, USA), which had a high-resolution,
phased-array transducer and a frequency that ranged from
7.0 to 12.0 MHz. Color and Power Doppler were available in
all equipment.
Imaging Interpretation
Mammograms were evaluated and reported by 2 of the
authors of this study (J.E. and V.F.M.) who had 13 and 12
years of experience reading mammograms, respectively. For
all patients, the mammographic findings were described
using the Bi-RADS lexicon. At the end of the experiment, a
final Bi-RADS category was reported. In addition to the Bi-
RADS category assigned, breast parenchymal density was
evaluated according to the Bi-RADS systematization. It was
categorized as follows: American College of Radiology
density 1 (ACR D1) was categorized as almost entirely fat
(less than 25% fibroglandular tissue); ACR D2 was catego-
rized as scattered fibroglandular densities (approximately
25% to 50% fibroglandular); ACR D3 was categorized as
heterogeneously dense (approximately 51% to 75% fibro-
glandular); and ACR D4 was categorized as dense (more
than 75% fibroglandular).
Mammograms were classified as Bi-RADS category 0
when the following criteria were met: 1) previous exams
were not available for comparison; 2) round or oval lesions,
which had either circumscribed or partially obscured
margins, were present; 3) focal asymmetry was seen on
two orthogonal incidences and persistent after additional
views.
All US examinations were performed by third-year
residents, but as an institutional rule, patients were re-
scanned by one of our faculty who had experience in breast
US ranging from 10 to 25 years and who were responsible
for the final report. The US examination was considered
diagnostic if the Bi-RADS category changed to 2, 4 or 5
based on the definitions suggested by Kubiak et al.15 If any
cases needed a follow-up mammography (e.g., due to an
asymmetry without corresponding findings in the ultra-
sound), then the US examination was considered indeter-
minate, and the mammogram category was changed to Bi-
RADS 3. The ultrasonographic criteria for probably benign
solid lesions were as follows: a) oval or round shape; b)
circumscribed margins; c) isoechoic, hyperechoic, or hypoe-
choic echo patterns; d) parallel orientation (i.e., ‘‘wider than
taller’’); and e) enhancement or no posterior acoustic
features. The lesions that met these criteria were classified
as Bi-RADS category 3, and only typical intramammary
lymph nodes were classified as Bi-RADS category 2. Lesions
were classified as suspicious when one of these criteria was
absent.
When indicated, tissue samples were obtained using fine
needle aspiration, using core biopsy or after open excision
by wire location according to the decision from the
Mastology Division. The samples were analyzed by two
experienced pathologists who were dedicated to the study
of breast diseases and had at least six years of experience in
this field.
Statistical Analysis
Statistical analysis included descriptive data and an
assessment of the degree of US resolution. The overall
performance of US was evaluated according to the pattern
of breast composition (D1 to D4, as per the Bi-RADS
classification), and according to the morphology of the
lesion, it was described on mammography using the Bi-
RADS lexicon. Statistical significance and confidence inter-
vals were calculated using computerized statistical software
(SPSS, version 12; SPSS, Chicago, Ill., USA). A p-value of less
than 0.05 indicated statistical significance. The diagnostic
effectiveness of US was evaluated using a confidence
interval of 95%.
RESULTS
From the initial 4,384 patients who had a mammography,
391 were classified as Bi-RADS category 0. The mean age of
the patients was 53.3 years (ranging from 35 to 81). After
applying the inclusion and exclusion criteria, 241 patients
had US, when adjuvant method was indicated.
All of the lesions or suspected findings in mammograms
in our study were nonpalpable, and the distribution
according to the Bi-RADS lexicon was as follows: 62 out of
241 (25.7%) were round or oval circumscribed lesions; 81 out
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of 241 (33.6%) were round lesions but with obscured
margins; 21 out of 241 (8.8%) were mass-like asymmetries;
38 out of 241 (15.7%) were focal asymmetries; 10 out of 257
(3.9%) cases had multiple round, circumscribed lesions; and
the remaining 29 cases had mixed findings (11.3%). Among
the 391 Bi-RADS category 0 mammograms, 302 (77.2%)
required additional views before a final classification was
made.
After US, the exams of 95 out of 241 (39.40%) patients
were considered indeterminate, with Bi-RADS category 3. In
146 cases (60.6%), US was considered diagnostic. In the
diagnostic group, US led to changing the Bi-RADS category
to benign (category 2) in 70.2% of cases (111/146), and for
the remaining 35 cases (29.8%), US led to a reclassification of
the level to category 4 (suspicious). None of the US
outcomes were classified as Bi-RADS category 5. For the
111 patients who had Bi-RADS reassigned to category 2, US
found cysts in 72 patients (64.9 %), ductal ectasia in 13 cases
(11.7%), ultrasonographic benign-appearing masses in 21
cases (18.9%), and other benign features, such as linear
scars, in 5 (4.5%) cases. The study results are summarized in
the flowchart (Table 1).
Regarding the 35 patients with Bi-RADS category 4,
which was determined by ultrasonography, 25 out of 35
(71.4%) patients had benign findings after the tissue was
sampled. However, cancer was found in 10 patients (28.6%)
from this group: 5 with Invasive Ductal Carcinoma
(Figure 1-A,B,C), 2 with Ductal Carcinoma in situ, 1 with
Invasive Lobular Carcinoma (Figure 2-A,B,C), 1 with a
malignant Phyllodes tumor, and 1 with an undifferentiated
carcinoma according to immunohistochemistry that was
probably associated with the uterine cervix. Mass lesions
were predominant in our study. Round or oval lesions,
either with circumscribed or indistinct margins, represented
62.5% of the total lesions. Over the follow-up period of at
least two years, no lesions that were defined as benign by
US were revealed to be malignant.
The fat composition of the breasts was as follows: 26 with
grade 1 composition (10.7%); 109 with grade 2 (45.2%); 75
with grade 3 (30.7%); and 32 with grade 4 (13.3%).
Regarding breast density, 6 malignant lesions were found
in the ACR-D2 group, 2 in the ACR-D3 group, and 2 in the
ACR-D4 group. As mentioned previously, the overall index
of resolution for US was 60.6% for patients that were
reclassified for Bi-RADS categories 2 and 4. When the
diagnostic performance of US was analyzed according to
breast parenchymal density, no significant difference was
observed between fatty (grades D1 and D2) and dense
breasts (grades D3 and D4) using the Chi-Square test, with
101 out of 135 cases (74.8%) for ACR D1 + D2 and 88 out of
107 (82.2%) for D3 + D4 (p = 0.22), respectively.
Furthermore, no significant differences were observed for
the distribution of cancer lesions (Table 2); 6 out of 135
(4.4%) patients had fatty breasts, and 4 out of 107 (3.7%)
patients had dense breasts (p = 0.44).
The overall diagnostic performance of US was calculated
assuming that all of the cases that were moved to Bi-RADS
category 2 or 3 were followed for a minimum period of two
Table 1 - Flowchart of BI-RADS 0 mammograms evaluated by ultrasonography.
Abbreviations: MMG = Mammograms; BI-RADS = Breast Imaging Reporting and Data System; Pts = Patients; US = Ultrasonography.
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years and thus represent true negative cases. The data are
shown in Table 3. The overall accuracy was 89.6%;
sensitivity was 100%; specificity was 89.1%; positive
predictive value (PPV) was 28.6%; and negative predictive
value (NPV) was 100%. When the total number of Bi-RADS
category 0 cases evaluated by US was considered, the
prevalence of cancer lesions was 10 out of 241 (4.1%).
DISCUSSION
US is widely used as a diagnostic tool in breast lesion
management. The accuracy of US in diagnosing solid breast
lesions has been extensively evaluated in the literature, and
it has been shown to vary from 68% to 96%.18 A reasonable
level of concordance exists for most US indications of breast
disease, including its use after a mammogram-rated Bi-
RADS 0 classification. Despite the extensive literature
regarding the role of US in classifying breast lesions, no
studies have addressed the performance of US after a
mammogram-rated Bi-RADS 0 classification.
Our study indicates that US provides a very efficient
alternative to a screening mammogram for obtaining more




Figure 1A - Oblique view of both breasts. A focal asymmetry is
seen in the left upper quadrant (arrow). B. Magnified cranio-
caudal view showed an irregular mass lesion and indistinct
margins (arrow). C. US revealed an irregular, hypoechoic mass





Figure 2 A-B - Oblique views of both breasts and a magnification
of the central region of the right breast. A subtle round
asymmetry is seen in the right breast (arrow in B), which was
found to be a cyst (not shown). C. Additionally, US demonstrated
an irregular mass, which was revealed to be Invasive Lobular
Carcinoma by histology.
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rationale for Bi-RADS category 0. Approximately two-thirds
(60.6%) of the mammograms in this study were reclassified
by US into more precise categories, which either permitted a
safe migration to routine screening (Bi-RADS category 2) or
triggered a tissue sampling procedure (Bi-RADS category 4).
This percentage is in agreement with several studies that
have shown a low cancer yield for breast biopsies indicated
by a single imaging method or by a combination of them.19-20
When considering all lesions (Bi-RADS categories 2, 3,
and 4), the negative predictive value of US was high
(100%), whereas the positive predictive value was low
(28.6%). This result can be partially explained by the low
prevalence of malignant lesions in this subset of patients (10/
241 or 4.1%). However, in this subgroup of patients, cancer
was not found that was not revealed by sonography within
the two-year follow-up period.We did not address the ability
of different sonographic criteria to predict malignancy
because the incidence of cancer in our sample population
was too low for this determination. The sensitivity of US in
our study was presumed to be 100%, which can be attributed
to multiple factors. First, a selected population screened by
mammography was used, and the correct use of the Bi-RADS
classification may have generated a sample population that
was dominated by a specific type of lesion (i.e., a mass),
which is more amenable to ultrasound evaluation.
Additionally, we acknowledge that a verification bias (see
comment below) might have overestimated the sensitivity.
A significant fraction of our patients (95/241 or 39.4%) was
classified as Bi-RADS category 3. We did not move those
patients whose exams were re-classified to Bi-RADS category
3 into the diagnostic group because we focused on a imme-
diate resolution, and discharged these cases as being
promptly solved by US.
Given the limitations of mammography for dense
breasts,9,21-23 such as the fact that density is considered
one of the major factors for reduced screening sensitivity in
women before the age of 50, one might expect that US
would be more helpful in this subgroup. In a previous study
by Leconte et al.,14 the sensitivity of US was equivalent for
all grades of density; however, the relative risk for detecting
nonpalpable cancers was significantly higher in grades 3
and 4. Similarly, in our study, the US sensitivity was
identical for all grades of density. However, no difference
was observed in the relative risk for detecting nonpalpable
cancers, which considered dense breasts to be grades 3 and
4 and fatty-replaced breasts to be grades 1 and 2. This
discrepancy is probably related to different study designs.
We only evaluated Bi-RADS category 0, but in the
aforementioned study, the authors assessed Bi-RADS
categories 1, 2, 4, and 5. In our study, the distribution of
Bi-RADS category 0 cases, as determined according to breast
parenchymal density, did not show any predominance. All
breast parenchymal density grades were almost equally
represented, and no significant difference was observed in
the performance outcome of US in each category. Although
routine association of ultrasonography and mammography
in women with dense breasts has been advocated by some
authors,8,9,24,25 our study did not assess whether this
association improves the assessment of dense breasts.
Because our study selected only Bi-RADS category 0
cases, a predominance of round or oval lesions was
observed; other shapes were underrepresented in our series
due to the lack of lesions that were rated Bi-RADS categories
4 and 5. Microcalcifications were absent from our series
because the current mammographic findings were sufficient
for the purposes of the classification and approach defini-
tions and because of the known limitations of US for these
patients these particular lesions.26,27
We acknowledge that some limitations are present in our
study. We used a conventional mammography system
instead of digital equipment. Although digital mammogra-
phy may improve the visualization of lesion details, the
actual impact of this advancement on diagnostic accuracy is
limited.28,29 A verification bias may also exist because we
cannot be sure that no cancer was present in patients who
only had a follow-up session. However, a two-year follow-
up was used to define stability; this period of time was
considered optimal because it has been used reliably in
several other studies.1,30-32 Another important issue was
that we did not evaluate the interobserver variability
because this was a retrospective study, and the mammo-
grams were classified as Bi-RADS category 0 by one of the
authors and not by consensus. Strict adherence to the Bi-
RADS criteria could decrease interobserver variability.
Regarding the US technique, we also acknowledge that this
method is strongly operator-dependent, but in a retro-
spective study, we could not have the same observers
performing all of the US exams. Every physician on our staff
had at least eight years of experience in US. Therefore, we
expect that interobserver variability was minimized but
may not have been eliminated.33
In conclusion, US improves lesion characterization after a
Bi-RADS 0 mammogram. This method has the potential
ability to alter the management of cases in which a biopsy
might be recommended, but the risk of carcinoma is
estimated to be relatively low. Because of its high sensitivity
and ability to detect lesions regardless of breast density, US
Table 2 - Diagnostic performance of US and the








Diagnostic US 101/135 (74.8%) 88/107 (82.2%) p=0.22
Breast Cancers found 6/135 (4.4%) 4/107(3.7%) p=0.44
Table 3 - Diagnostic performance of ultrasonography.
TEST RESULT Disease + Disease - Total
US + 10 (TP) 25 (FP) 35
US - 0 (FN) 206 (TN) 206
Total 10 231 241
Parameter Formula Value (%)
95% Confidence
Interval
Sensitivity TP/TP+FN 100.0 65.5 – 100.0
Specificity TN/TN+FP 89.1 84.2 –92.7
Accuracy TP+TN/Total 89.6 83.3 – 94.1
PPV TP/TP+FP 28.6 15.2 – 46.5
NPV TN/TN+FN 100.0 97.7 – 100.0
Error Rate FP+FN/Total 10.4 6.7-13.1
Prevalence TP+FN/Total 4.1 2.1-7.7
Abbreviations: US + = Ultrasound positive for cancer; US - = Ultrasound
negative for cancer; FN = False negative; FP = False positive; TN = True
negative; TP = True positive; PPV = Positive predictive value;
NPV = Negative predictive value.
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performance is recommended as the first choice for follow-
up evaluations of lesions that are classified as Bi-RADS 0.
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